Jane Alavi, MD and Jim Dattilo
Ultima Vez Modificado: 1 de noviembre del 2001
My uncle was diagnosed as having a malignant astrocytoma brain tumor. His physician suggested researching "cereport" treatment. We have been unable to access any information on this therapy. Can you please explain this treatment and where we may find additional information? Also, are you aware of any other new or alternative treatments for this condition?
Thank you so much for your help.
Jane Alavi, MD and Jim Dattilo from the Brain Tumor Center at Abramson Cancer Center of the University of Pennsylvania respond:
One of the greatest obstacles in using chemotherapy is in drugs crossing the "blood brain barrier" - the protective filter of the brain that selectively controls what goes into the brain. The new drug, Cereport, is designed to temporarily open the "blood brain barrier" to allow drugs, such as chemotherapy, to enter the brain, and in turn give a better effect on treating the tumor. While Cereport has shown some promise in the laboratory and is now being tested in humans, it is still an investigational treatment and not widely available. We would recommend that you ask your physician to contact Alkermes, Inc, the drug manufacturer, to find out about clinical trials that are available for malignant astrocytoma.
May 11, 2012 - In children and adolescents with brain tumors treated with proton radiation, health-related quality of life scores are affected by both disease type and treatment, with assessments made by the patients correlating well with those of their parents, according to a study published online May 7 in the Journal of Clinical Oncology.
Nov 27, 2014
Nov 27, 2014